Also trades as: 9989.T (JPX) · $vol 13M

$28.18

+0.00 (+0.00%)

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 46 · $3.3B mcap · 66M float · 0.0004% daily turnover

Revenue

$847.8B +5.7% ▲

5Y CAGR: +6.0%

Gross Profit

$198.7B -2.7% ▼

5Y CAGR: +168.1%

Operating Income

$47.1B +5.9% ▲

5Y CAGR: +4.8%

Net Income

$31.6B +2.7% ▲

5Y CAGR: +4.5%

EPS (Diluted)

$270.03 +2.7% ▲

5Y CAGR: +4.5%

EBITDA

$66.0B +8.2% ▲

5Y CAGR: +7.6%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$648.7B	$690.5B	$751.8B	$801.8B	$847.8B
YoY Growth	+2.3%	+6.4%	+8.9%	+6.7%	+5.7%
Cost of Revenue	$4.0B	$3.9B	$562.5B	$597.7B	$649.2B
Gross Profit	$1.3B	$1.3B	$189.3B	$204.1B	$198.7B
Gross Margin	0.2%	0.2%	25.2%	25.5%	23.4%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$1.0B	$1.0B	-$5M	$142.3B	$151.5B
Operating Expenses	$1.0B	$1.0B	$148.3B	$159.6B	$151.5B
Operating Income	$34.1B	$37.5B	$41.0B	$44.5B	$47.1B
Operating Margin	5.2%	5.4%	5.5%	5.5%	5.6%
Interest Expense	$9M	$36M	$32M	$164M	$386M
Income Before Tax	$34.7B	$37.7B	$41.3B	$43.6B	$46.1B
Tax Expense	$10.8B	$12.0B	$12.1B	$12.8B	$14.5B
Net Income	$23.9B	$25.7B	$29.1B	$30.8B	$31.6B
Net Margin	3.7%	3.7%	3.9%	3.8%	3.7%
EPS (Diluted)	$204.01	$219.82	$249.07	$262.91	$270.03
EBITDA	$44.9B	$49.8B	$56.1B	$61.0B	$66.0B
Shares Outstanding	117M	117M	117M	117M	117M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$194.6B	$201.0B	$208.0B	$198.2B	$207.7B	$213.8B	$217.5B	$208.1B
Cost of Revenue	$145.4B	$150.5B	$154.2B	$147.6B	$154.4B	$159.4B	$161.4B	$159.5B
Gross Profit	$49.2B	$50.5B	$53.8B	$50.6B	$53.3B	$54.3B	$56.1B	$48.6B
Gross Margin	25.3%	25.1%	25.9%	25.5%	25.7%	25.4%	25.8%	23.3%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$38.2B	$40.2B	$40.2B	$23.6B	$41.1B	$43.4B	$42.6B	$43.2B
Operating Expenses	$38.2B	$40.2B	$40.2B	$40.9B	$41.1B	$43.4B	$42.6B	$43.2B
Operating Income	$10.9B	$10.3B	$13.6B	$9.7B	$12.3B	$10.9B	$13.5B	$5.4B
Operating Margin	5.6%	5.1%	6.5%	4.9%	5.9%	5.1%	6.2%	2.6%
Interest Expense	$0	$0	$15M	$3M	$50M	$89M	$91M	$126M
Income Before Tax	$10.6B	$9.9B	$13.5B	$9.6B	$12.1B	$10.8B	$13.3B	$9.9B
Tax Expense	$3.3B	$2.9B	$4.0B	$2.7B	$4.1B	$3.3B	$4.3B	$2.7B
Net Income	$7.3B	$7.0B	$9.6B	$6.9B	$7.9B	$7.4B	$9.0B	$7.2B
Net Margin	3.7%	3.5%	4.6%	3.5%	3.8%	3.5%	4.1%	3.5%
EPS (Diluted)	$62.33	$59.68	$81.73	$59.16	$67.92	$63.00	$76.86	$62.31
EBITDA	$14.7B	$14.4B	$17.4B	$14.0B	$16.6B	$15.5B	$18.3B	$10.4B
Shares Outstanding	117M	117M	117M	117M	117M	117M	117M	117M

SDGCF OTC